Holen Sie sich die Stockscreener-App
73.75
1.03%
0.75
Handel nachbörslich:
73.75
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CTVA?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$73.00
Offen:
$73.16
24-Stunden-Volumen:
3.73M
Relative Volume:
0.98
Marktkapitalisierung:
$50.31B
Einnahmen:
$16.83B
Nettoeinkommen (Verlust:
$1.14B
KGV:
44.97
EPS:
1.64
Netto-Cashflow:
$2.10B
1W Leistung:
+2.30%
1M Leistung:
+0.04%
6M Leistung:
+17.98%
1J Leistung:
+34.65%
1-Tages-Spanne:
$73.01
$74.30
1-Wochen-Bereich:
$71.78
$74.30
52-Wochen-Spanne:
$50.30
$77.41
Corteva Inc Stock (CTVA) Company Profile
Firmenname
Corteva Inc
Sektor
Branche
Telefon
(833) 267-8382
Adresse
9330 ZIONSVILLE ROAD, INDIANAPOLIS, DE
Vergleichen Sie CTVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTVA
Corteva Inc
|
73.75 | 49.18B | 16.83B | 1.14B | 2.10B | 1.64 |
|
NTR
Nutrien Ltd
|
60.03 | 29.19B | 25.68B | 527.00M | 839.00M | 1.07 |
|
CF
Cf Industries Holdings Inc
|
91.72 | 15.54B | 6.13B | 1.34B | 1.86B | 7.59 |
|
MOS
Mosaic Company
|
35.90 | 11.39B | 11.06B | 367.80M | 212.50M | 1.16 |
|
ICL
Icl Group Ltd
|
6.87 | 8.80B | 6.84B | 407.00M | 755.00M | 0.32 |
Corteva Inc Stock (CTVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-31 | Hochstufung | Argus | Hold → Buy |
| 2025-03-13 | Eingeleitet | Goldman | Buy |
| 2024-10-23 | Eingeleitet | Citigroup | Buy |
| 2024-10-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-08-07 | Herabstufung | Argus | Buy → Hold |
| 2024-04-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-03-01 | Eingeleitet | Wolfe Research | Outperform |
| 2024-02-12 | Hochstufung | Loop Capital | Hold → Buy |
| 2024-02-02 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2023-11-27 | Herabstufung | Berenberg | Buy → Hold |
| 2023-11-14 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-10-20 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-09-05 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-25 | Herabstufung | Redburn | Buy → Neutral |
| 2023-06-28 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-22 | Hochstufung | Vertical Research | Hold → Buy |
| 2023-04-06 | Eingeleitet | Oppenheimer | Perform |
| 2023-01-19 | Eingeleitet | Wells Fargo | Overweight |
| 2023-01-11 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-11-16 | Herabstufung | UBS | Buy → Neutral |
| 2022-11-15 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-08-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-08-08 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2022-07-14 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-01 | Eingeleitet | Barclays | Overweight |
| 2022-05-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-14 | Hochstufung | Loop Capital | Hold → Buy |
| 2022-04-14 | Herabstufung | Vertical Research | Buy → Hold |
| 2022-01-31 | Hochstufung | Redburn | Neutral → Buy |
| 2021-10-18 | Herabstufung | Loop Capital | Buy → Hold |
| 2021-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-10-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-09-01 | Eingeleitet | Berenberg | Buy |
| 2021-08-09 | Hochstufung | Monness Crespi & Hardt | Sell → Neutral |
| 2021-05-10 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-04-19 | Hochstufung | Loop Capital | Hold → Buy |
| 2021-02-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-02-05 | Bestätigt | Monness Crespi & Hardt | Sell |
| 2020-12-18 | Herabstufung | Susquehanna | Positive → Neutral |
| 2020-12-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-11-10 | Hochstufung | Argus | Hold → Buy |
| 2020-10-19 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-10-19 | Herabstufung | Exane BNP Paribas | Outperform → Underperform |
| 2020-08-11 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-08-10 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-07-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2020-06-26 | Eingeleitet | Cleveland Research | Neutral |
| 2020-06-16 | Hochstufung | Vertical Research | Hold → Buy |
| 2020-06-08 | Herabstufung | Monness Crespi & Hardt | Neutral → Sell |
| 2020-05-11 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-04-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2020-04-17 | Hochstufung | Loop Capital | Sell → Hold |
| 2020-04-01 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-31 | Hochstufung | Susquehanna | Neutral → Positive |
| 2020-03-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-19 | Hochstufung | Edward Jones | Hold → Buy |
| 2020-03-13 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-03-10 | Hochstufung | Monness Crespi & Hardt | Sell → Neutral |
Alle ansehen
Corteva Inc Aktie (CTVA) Neueste Nachrichten
What analysts say about Corteva Inc. stockMarket-beating returns - jammulinksnews.com
Is Corteva Inc. a good long term investmentFree Popular Stock Recommendations - jammulinksnews.com
What drives Corteva Inc. stock priceFree Consultation - jammulinksnews.com
Corteva Inc. Stock Analysis and ForecastTremendous return rates - jammulinksnews.com
Corteva's Quarterly Earnings Preview: What You Need to Know - MSN
Corteva Sees Increased Price Target with Strong Buy Rating - AInvest
Corteva's (NYSE:CTVA) investors will be pleased with their splendid 172% return over the last five years - Yahoo Finance
3rd Circ. Won't Halt Corteva Pension Judgment For Appeal - Law360
Lobbying Update: $900,000 of CORTEVA AGRISCIENCE LLC (FKA E I DU PONT DE NEMOURS AND COMPANY) lobbying was just disclosed - Quiver Quantitative
Corteva (CTVA) Sees Increased Price Target with Strong Buy Ratin - GuruFocus
Corteva's Quarterly Earnings Preview: What You Need To Know - Barchart.com
Corteva, Inc. (CTVA) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance
Farm Hands on the Potomac: Modisett Kemp to lead government affairs at Corteva, Simpson assumes leadership of NCFC - Agri-Pulse
Lobbying Update: $60,000 of CORTEVA AGRISCIENCE lobbying was just disclosed - Quiver Quantitative
Fund Update: Ballentine Partners, LLC added 120,908 shares of CORTEVA ($CTVA) to their portfolio - Quiver Quantitative
Oppenheimer Adjusts Corteva Price Target to $87 From $75, Maintains Outperform Rating - MarketScreener
Mizuho Securities Adjusts Corteva Price Target to $85 From $80, Maintains Outperform Rating - MarketScreener
Corteva (CTVA) Partners Micropep Technologies on Sustainable Crop Protection - MSN
(CTVA) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Corteva Stock Slides 5.20% in Six Days, Trading Volume Drops to 451st Rank - AInvest
We Think Corteva (NYSE:CTVA) Can Stay On Top Of Its Debt - simplywall.st
KeyBanc Capital Adjusts Price Target on Corteva to $84 From $72, Maintains Overweight Rating - MarketScreener
Keybanc Analyst Raises Price Target for Corteva (CTVA) to $84 | - GuruFocus
Keybanc Analyst Raises Price Target for Corteva (CTVA) to $84 | CTVA Stock News - GuruFocus
Biological Nutrition Seed Treatment Supports Uniform Corn Emergence - Dakota News Network
Corteva stock price target raised to $85 from $74 at RBC Capital By Investing.com - Investing.com South Africa
A Glimpse Into The Expert Outlook On Corteva Through 14 Analysts - Benzinga
Corteva stock price target raised to $85 from $74 at RBC Capital - Investing.com Nigeria
RBC Raises Price Target on Corteva to $85 From $74, Keeps Outperform Rating - MarketScreener
Best Agriculture Stocks Worth WatchingJuly 9th - MarketBeat
UBS Raises Price Target on Corteva to $90 From $76, Maintains Buy Rating - MarketScreener
CTVA: UBS Raises Corteva Price Target to $90 with Buy Rating | C - GuruFocus
UBS Increases Price Target for Corteva (CTVA) to $90 | CTVA Stoc - GuruFocus
CTVA: BMO Capital Raises Price Target for Corteva to $86 | CTVA Stock News - GuruFocus
Corteva Q2 Preview: Potential Benefit From Positive Biofuel Policy In Brazil (CTVA) - Seeking Alpha
BMO Capital raises Corteva stock price target to $86 on strong growth profile By Investing.com - Investing.com South Africa
Wells Fargo Hikes Corteva (CTVA) Price Target Affirms ‘Overweight’ Rating - MSN
BMO Capital raises Corteva stock price target to $86 on strong growth profile - Investing.com Canada
Finanzdaten der Corteva Inc-Aktie (CTVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):